Medtronic plc — Director's Dealing 2021

Mar 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-03-02

Reporting Person: TEN HOEDT ROB (EVP & President EMEA)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-02	Ordinary Shares	M	7168	$34.88	Acquired	50965	Direct
2021-03-02	Ordinary Shares	S	7168	$117.98	Disposed	43797	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-02	Stock Option (Right to Buy)	$34.88	M	7168	Disposed	2021-08-01	Ordinary Shares (7168)	Direct

Footnotes

F1: This balance increased by 321 shares due to exempt transactions such as dividend reinvestment.

F2: This option to purchase 7,168 Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 7,168 Medtronic Inc. common stock shares for $34.88 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.